CEPI | Latest News & Updates - Dec 12, 2024 Release
CEPI is funding up to $10.3 million for the ACHIEVE study on chikungunya over three years...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
CEPI
🌎 cepi.netCEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership established in 2017 to accelerate the development of vaccines against future epidemics. It focuses on developing vaccines for various pathogens, including Ebola, Lassa virus, and COVID-19, and aims to compress vaccine development timelines to 100 days. CEPI also invests in platform technologies for rapid vaccine development and ensures fair allocation of vaccines worldwide through initiatives like COVAX.
CEPI - Latest News and Updates
- CEPI is funding up to $10.3 million for the ACHIEVE study on chikungunya over three years.
- CEPI is providing up to USD 40 million in initial funding to support SK bioscience's joint R&D project for mRNA vaccine development.
- CEPI is giving £2.16 million to UK CPI to advance the University of Toronto's MANGO device for automating Virus-Like Particle manufacturing.
- CEPI is seeking an Executive Director of People & Organisation to lead HR initiatives and support its mission to reduce epidemic risks.
- Dr. Sall has joined CEPI in a new role, as announced by the Global Virus Network on December 10.
- CEPI has partnered with Accumulus Synergy to enhance information equity and accelerate vaccine access by supporting a regulatory collaboration platform with $19.1 million in funding.
- Dr Sall will lead CEPI's manufacturing and supply chain strategy to improve global epidemic and pandemic preparedness by increasing manufacturing capacity in underserved regions.
- CEPI is supporting new research with the University of Oxford and scientists in Kenya and Tanzania to assess Chikungunya disease burden in East Africa.
- Sarah Roberts has left CEPI as the Head of R&D Events & Admin in the United Kingdom to join CityZen Property Management LTD as the Client Accounts & Contract Compliance Manager.
- Dr. Amadou Alpha Sall has been appointed as Executive Director of Manufacturing and Supply Chain at CEPI.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.